Roche Diagnostics Corp. moves to #1 spot in U.S. in vitro Diagnostics marketplace

Roche Diagnostics was named the number one in vitro diagnostics company in the United States, according to a marketplace analysis by Boston BioMedical Consultants, Inc. Roche Diagnostics' United States sales revenues in year 2000 grew by 10 percent for an overall share of 16 percent of the total United States in vitro diagnostics market. The United States in vitro diagnostics market growth for year 2000 was 5 percent.

The number-one ranking stems from the company's extensive product lines, which include predisposition screening, targeted monitoring, prevention, diagnosis, therapy and therapy monitoring systems, as well as its pipeline of new technology-based products. Roche Diagnostics products help enhance health, well-being and quality of life, and span a variety of markets, which serve scientists, researchers, physicians and patients through innovative, cost-effective and reliable diagnostic systems that assist in medical research.

"First and foremost, our business is driven by our customers' needs. Our goal is to provide the highest quality and most innovative products across all of the markets we serve," stated Martin Madaus, president and CEO of Roche Diagnostics Corporation.

Madaus acknowledged the role that Roche Diagnostics employees contributed to the company's success. "Our employees are dedicated to providing tailor-made, high-quality solutions for our customers," Madaus said.

"Roche Diagnostics inspires innovation, creativity and productivity by giving employees resources, support and latitude; a challenging and creative environment; variety and real growth opportunities; and recognition through benefits and rewards," Madaus added.

Roche Diagnostics recently unveiled a new strategic vision and plan designed to help the company retain its leadership position. The company will use technology to create innovative, pioneering solutions; connect patients and providers via actionable health information and data; and ensure that customer needs continue to drive the development of new products.

"We also plan to grow our business through new e-commerce capabilities and by leveraging the Internet to reach customers and reduce costs," Madaus said.